Article
Cell therapy for Parkinson’s disease with induced pluripotent stem cells
27 Feb 2023
Abstract excerpt
Parkinson's disease (PD) is the second most common neurodegenerative disease and a prime target of cell therapies. In fact, aborted fetal tissue has been used as donor material for such therapies since the 1980s. These cell therapies, however, suffer from several problems, such as a short supply of donor materials, quality instability of the tissues, and ethical restrictions. The advancement of stem cell...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
